BACKGROUND: Helicobacter cinaedi, an enterohepatic helicobacter species (EHS), is an important human pathogen and is associated with a wide range of diseases, especially in immunocompromised patients. It has been convincingly demonstrated that innate immune response to certain pathogenic enteric bacteria is sufficient to initiate colitis and colon carcinogenesis in recombinase-activating gene (Rag)-2-deficient mice model. To better understand the mechanisms of human IBD and its association with development of colon cancer, we investigated whether H. cinaedi could induce pathological changes noted with murine enterohepatic helicobacter infections in the Rag2(-/-) mouse model. MATERIALS AND METHODS: Sixty 129SvEv Rag2(-/-) mice mouse were experimentally or sham infected orally with H. cinaedi strain CCUG 18818. Gastrointestinal pathology and immune responses in infected and control mice were analyzed at 3, 6 and 9 months postinfection (MPI). H. cinaedi colonized the cecum, colon, and stomach in infected mice. RESULTS: H. cinaedi induced typhlocolitis in Rag2(-/-) mice by 3 MPI and intestinal lesions became more severe by 9 MPI. H. cinaedi was also associated with the elevation of proinflammatory cytokines, interferon-γ, tumor-necrosis factor-α, IL-1β, IL-10; iNOS mRNA levels were also upregulated in the cecum of infected mice. However, changes in IL-4, IL-6, Cox-2, and c-myc mRNA expressions were not detected. CONCLUSIONS: Our results indicated that the Rag2(-/-) mouse model will be useful to continue investigating the pathogenicity of H. cinaedi, and to study the association of host immune responses in IBD caused by EHS.
BACKGROUND:Helicobacter cinaedi, an enterohepatic helicobacter species (EHS), is an important human pathogen and is associated with a wide range of diseases, especially in immunocompromised patients. It has been convincingly demonstrated that innate immune response to certain pathogenic enteric bacteria is sufficient to initiate colitis and colon carcinogenesis in recombinase-activating gene (Rag)-2-deficient mice model. To better understand the mechanisms of human IBD and its association with development of colon cancer, we investigated whether H. cinaedi could induce pathological changes noted with murineenterohepatic helicobacter infections in the Rag2(-/-) mouse model. MATERIALS AND METHODS: Sixty 129SvEv Rag2(-/-) micemouse were experimentally or sham infected orally with H. cinaedi strain CCUG 18818. Gastrointestinal pathology and immune responses in infected and control mice were analyzed at 3, 6 and 9 months postinfection (MPI). H. cinaedi colonized the cecum, colon, and stomach in infected mice. RESULTS: H. cinaedi induced typhlocolitis in Rag2(-/-) mice by 3 MPI and intestinal lesions became more severe by 9 MPI. H. cinaedi was also associated with the elevation of proinflammatory cytokines, interferon-γ, tumor-necrosis factor-α, IL-1β, IL-10; iNOS mRNA levels were also upregulated in the cecum of infected mice. However, changes in IL-4, IL-6, Cox-2, and c-myc mRNA expressions were not detected. CONCLUSIONS: Our results indicated that the Rag2(-/-) mouse model will be useful to continue investigating the pathogenicity of H. cinaedi, and to study the association of host immune responses in IBD caused by EHS.
Authors: J Pasternak; R Bolivar; R L Hopfer; V Fainstein; K Mills; A Rios; G P Bodey; C L Fennell; P A Totten; W E Stamm Journal: Ann Intern Med Date: 1984-09 Impact factor: 25.391
Authors: Charles G Knutson; Aswin Mangerich; Yu Zeng; Arkadiusz R Raczynski; Rosa G Liberman; Pilsoo Kang; Wenjie Ye; Erin G Prestwich; Kun Lu; John S Wishnok; Joshua R Korzenik; Gerald N Wogan; James G Fox; Peter C Dedon; Steven R Tannenbaum Journal: Proc Natl Acad Sci U S A Date: 2013-06-10 Impact factor: 11.205
Authors: S E Erdman; V P Rao; T Poutahidis; A B Rogers; C L Taylor; E A Jackson; Z Ge; C W Lee; D B Schauer; G N Wogan; S R Tannenbaum; J G Fox Journal: Proc Natl Acad Sci U S A Date: 2009-01-21 Impact factor: 11.205
Authors: Susan E Erdman; Varada P Rao; Theofilos Poutahidis; Melanie M Ihrig; Zhongming Ge; Yan Feng; Michal Tomczak; Arlin B Rogers; Bruce H Horwitz; James G Fox Journal: Cancer Res Date: 2003-09-15 Impact factor: 12.701
Authors: Michael Y Esmail; Rebecca Bacon; Alton G Swennes; Yan Feng; Zeli Shen; AnaPatricia Garcia; Prachi Sharma; Joyce Cohen; James G Fox Journal: Helicobacter Date: 2015-10-19 Impact factor: 5.753
Authors: Z Shen; A Mannion; M T Whary; S Muthupalani; A Sheh; Y Feng; G Gong; P Vandamme; H R Holcombe; B J Paster; J G Fox Journal: Infect Immun Date: 2016-07-21 Impact factor: 3.441
Authors: Zeli Shen; Anthony Mannion; Maggie Lin; Michael Esmail; Vasudevan Bakthavatchalu; Stephanie Yang; Calvin Ho; Yan Feng; Briony Smith; James Elliott; Vince Gresham; John L VandeBerg; Paul B Samollow; James G Fox Journal: Int J Syst Evol Microbiol Date: 2020-12 Impact factor: 2.747
Authors: Zeli Shen; Yan Feng; Sureshkumar Muthupalani; Alexander Sheh; Lenzie E Cheaney; Christian A Kaufman; Guanyu Gong; Bruce J Paster; James G Fox Journal: Carcinogenesis Date: 2016-09-21 Impact factor: 4.944